Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Search content at Albert Einstein College of Medicine
Home
Faculty
Departments
Grants
Publications
Prizes
Hypoglycemic effect of combined ghrelin and glucagon receptor blockade
Bharath K. Mani
, Aki Uchida
, Young Lee
, Sherri Osborne-Lawrence
,
Maureen J. Charron
, Roger H. Unger
, Eric D. Berglund
, Jeffrey M. Zigman
Biochemistry
Research output
:
Contribution to journal
›
Article
›
peer-review
31
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hypoglycemic effect of combined ghrelin and glucagon receptor blockade'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Ghrelin
100%
Hypoglycemic Activity
100%
Blood Glucose
100%
Glucagon Receptor
100%
Receptor Blockade
100%
Ghrelin Level
100%
Ghrelin Receptor
100%
Plasma Ghrelin
100%
Hyperglycemia
75%
Knock-in Mouse Model
75%
Glucagon
75%
Insulin
50%
Hypoglycemia
50%
Type I Diabetes
50%
Monoclonal Antibody
50%
Type 1 Diabetes Mellitus (T1DM)
50%
Streptozotocin
50%
Diabetes
25%
Streptozotocin-induced
25%
Null Mice
25%
Glucagon Receptor Knockout
25%
Monotherapy
25%
Glycemia
25%
Low Blood Glucose
25%
Ghrelin Receptor Antagonist
25%
Db Mice
25%
Level Rise
25%
Pancreatic β
25%
Pharmacology, Toxicology and Pharmaceutical Science
Ghrelin
100%
Ghrelin Receptor
100%
Glucagon Receptor
100%
Antidiabetic Activity
100%
Glucose
62%
Knockout Mouse
50%
Hyperglycemia
37%
Glucagon
37%
Streptozotocin
37%
Hypoglycemia
25%
Monoclonal Antibody
25%
Insulin Dependent Diabetes Mellitus
25%
Insulin
25%
Antidiabetic Agent
12%
Monotherapy
12%
Db/Db Mouse
12%
Receptor Antagonist
12%
Controlled Release
12%
Cytotoxin
12%
Neuroscience
Glucagon Receptor
100%
Ghrelin
100%
Growth Hormone Secretagogue Receptor
100%
Glucose
62%
Blood Plasma
50%
Streptozotocin
37%
Hyperglycemia
37%
Glucagon
37%
Hypoglycemia
25%
Monoclonal Antibody
25%
Insulin
25%
Receptor Antagonist
12%